Teladoc Health (TDOC) to Release Quarterly Earnings on Wednesday

Teladoc Health (NYSE:TDOC) is expected to issue its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.21) per share and revenue of $639.44 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Teladoc Health Price Performance

Shares of TDOC opened at $11.40 on Tuesday. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock’s 50 day moving average is $10.56 and its two-hundred day moving average is $9.50. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $15.95. The firm has a market capitalization of $1.96 billion, a PE ratio of -1.97 and a beta of 1.04.

Insider Activity at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the transaction, the insider now owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Oppenheimer dropped their price objective on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. The Goldman Sachs Group increased their price target on shares of Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a report on Tuesday, February 18th. Piper Sandler reissued an “overweight” rating and set a $13.00 price objective (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Finally, Royal Bank of Canada lifted their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Thirteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $11.81.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.